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ABSTRACT. Osteoarthritis (OA) is a pathology that ultimately causes joint destruction. 
The cartilage is one of the principal affected tissues. Alterations in the lipid mediators 
and an imbalance in the metabolism of cells that form the cartilage (chondrocytes), have 
been described as contributors to the OA development. In this study, we have studied the 
distribution of lipids and chemical elements in healthy and OA human cartilage. Time of 
flight secondary ion mass spectrometry (TOF-SIMS) allows us to study the spatial 
distribution of molecules at a high resolution on a tissue section. TOF-SIMS revealed a 
specific peak profile that distinguishes healthy from OA cartilages. The spatial 
distribution of cholesterol-related peaks exhibited a remarkable difference between 
healthy and OA cartilages. A distinctive co-localization of cholesterol and other lipids in 
the superficial area of the cartilage was found. A higher intensity of oleic acid and other 
fatty acids in the OA cartilages exhibited a similar localization. On the other hand, CN
-
 
was observed with a higher intensity in the healthy samples. Finally, we observed an 
accumulation of calcium and phosphate ions exclusively in areas surrounding the 
chondrocyte in OA tissues. To our knowledge, this is the first time that TOF-SIMS 
revealed combined changes in the molecular distribution in the OA human cartilage.  
 
 
KEYWORDS: Time of flight secondary ion mass spectrometry, lipids, elemental ions, 
osteoarthritis, cartilage. 
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INTRODUCTION 
 
Osteoarthritis (OA) is one of the most prevalent rheumatic diseases affecting more than a 
half of the population above sixty years of age (1). The main characteristic of the disease 
is the progressive loss of cartilage due to the imbalance between synthesis and 
degradation of the cartilage matrix (2). However, its precise etiology is still far from 
understood, and results in the lack of adequate biomarkers for early diagnosis and 
prediction of eventual joint damage. For these reasons, no  complete and efficient 
treatment exists: the available therapies primarily comprise joint replacement, analgesics 
and inflammatory drug administration (3). Recent studies suggest that OA is a disease 
resulting from multiple pathophysiological mechanisms in which local and systemic 
factors play a role (4).  It has been suggested that OA is likely to be a systemic disease 
involving lipid metabolism, as generalized changes in many tissues of the joints have 
been observed including adiposity (5, 6).  In epidemiological studies, obesity coincided 
with a high incidence of non load-bearing types of OA, such as hand OA, suggesting a 
systemic disorder (7, 8). In general, lipids like cholesterol have been recognized as key 
regulators of normal vertebrate embryogenesis. However, excessive accumulation of 
cholesterol is toxic for the cells. This accumulation is prevented by tight regulation of 
infflux and efflux pathways (9). The only cell type present in cartilage (chondrocyte) is 
responsible to maintain the tissue homeostasis. Disorders in the lipid metabolism but also 
an imbalance in ion pumps and ion regulation, are linked to cell death and to cartilage 
destruction (10, 11).  
Different methods have been used in the past to study lipids and small molecules 
in biological tissues. Electromicroscopy provides information about lipids in relation to 
organelles. Histochemical staining with Oil Red O or Sudan dye is used to 
nonspecifically localize lipids, while lipid-specific fluorescence probes are available for 
cholesterol only. Chromatographic methods previously used for lipid identification in the 
cartilage include gas chromatography, thin layer chromatography and high-performance 
liquid chromatography (HPLC) (12, 13). However, these techniques require extraction 
steps that are time consuming, need large amounts of tissues and often result in lipid 
mobilization. Moreover, these techniques cannot reveal the heterogeneous spatial 
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distribution of lipids in the biological tissues. Imaging mass spectrometry (IMS) is a 
technique used in mass spectrometry to visualize the spatial distribution of compounds, 
metabolites, peptides or proteins by their molecular masses. Among the imaging 
techniques, time of flight secondary ion mass spectrometry imaging (TOF-SIMS) affords 
molecule-specific local information without the incorporation of a dye, isotopes or labels. 
Static TOF-SIMS is a surface-sensitive method where the primary ion dose is low, 
providing molecular information of the sample surface with minor damage (14, 15). In 
TOF-SIMS, the primary beam desorbs and ionizes molecular species from the sample 
surface, causing ejection of a large number of secondary ions that can be separated by 
mass (16). Displaying the mass spectra collected from the sample, we can generate 
chemical images. Thus, it allows us to compare the local signal intensity of different 
molecules in a biological tissue section. The use of surface metallization can also enhance 
the desorption/ionization of membrane components such as lipids and sterols of tissues 
and cells (17). Several studies have been successful in identifying intracellular 
distributions of specific biological ions, such as sodium, calcium, and membrane lipid 
fragments using TOF-SIMS (18-20). Other groups have described a potassium ion 
localization by 3D imaging TOF-SIMS specifically in thyroid tumor cells (21). 
Applications of the technology to the biomedical field have been also exploited. For 
instance, molecular ions from phosphatidylcholine, phosphatidylglycerol and protein 
fragments discriminate groups with asthma and healthy controls (22). Human striated 
muscle samples, from male control and Duchenne Muscular Dystrophy-affected children, 
have been subjected to TOF-SIMS detecting a different fatty acid (FA) chains 
composition depending on the local damage (23). Although this is a promising and 
widely known method, only a few studies have employed the technology to analyze the 
cartilage composition (24, 25) but none of them describe and compare the molecular 
distribution of human control and diseased OA cartilage by SIMS. 
In this work we have employed TOF-SIMS to study the differences in the 
composition of healthy and OA human cartilage aiming to contribute to the 
understanding of lipid and ion regulation in OA cartilage.  
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EXPERIMENTAL SECTION 
 
Cartilage procurement and processing 
 
Control human knee cartilage from adult donors with no history of joint disease was 
provided by the Tissue Bank and the Autopsy Service at CHU de La Coruña, Spain. 
Osteoarthritic (OA) cartilage was obtained from consenting donors who were undergoing 
joint replacement. Cartilage slices were removed from the condyles under aseptic 
conditions and frozen in liquid N2. For tissue studies, pieces of 10 µm of thickness were 
cut in a cryostate and deposited on indium tin oxide (ITO) high conductivity slides (Delta 
Technologies, CO, USA) and frozen at -20ºC. This study was approved by the local 
ethics committee in Galicia, Spain. 
 
Metal deposition 
 
Samples were kept in a desiccator box, defrosted and dried in a vacuum desiccator to 
prevent the molecular de-localization prior the metal deposition. Two 2 nm of gold was 
deposited on top of the samples using a Quorum Technologies (Newhaven East Sussex, 
UK) SC7640 sputter coated equipped with a FT707 quartz crystal microbalance stage to 
enable metal assisted secondary ion mass spectrometry (MetA-SIMS). A FT7690 film 
thickness monitor was used throughout the deposition process. 
 
TOF-SIMS experiments 
TOF-SIMS experiments were performed in positive and negative modes on a Physical 
Electronics (Eden Prairie, MN, USA) TRIFTII secondary ion mass spectrometer with an 
Au
1+
 primary ion beam. Experiments were performed with a primary ion beam of 7.2 nA, 
a primary pulse length of 19 ns and a dose of 4.47x10^11 ions/cm
2
 on the sample surface. 
This value is below 10^13 ions/cm
2
, also called static limit which means that 
measurement was terminated before the surface had been significantly damaged by the 
primary ion beam. The sample surface was observed continuously during the analysis 
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using an integrated video camera. Areas of 2x2 mm were analyzed using the mosaic 
mode of 2569x256 pixels per tile. The raster size was set at 125 µm per tile and a lateral 
resolution of 488 nm. The acquisition time was 10 seconds per tile. The data acquisition 
was performed with the software WinCadence version 4.4.0.17 also used for data 
visualization (PhysicaL Electronics, Chanhassan, USA).  
Data interpretation 
 
The supplementary figure 1 describes the data analyses workflow. Briefly, raw data was 
converted to Matlab format. Spatial binning, spectral binning and peak picking were 
performed prior selecting the 500 m/z channels with the highest variance. After selecting 
the regions of interest (ROI), a total of 10983 and 5727 spectra, acquired in positive and 
negative mode respectively, were used for the analysis. Principal component analysis 
(PCA) was used to look for spectral similarities and differences between the samples 
using our in-house built ChemomeTricks toolbox for MATLAB version 2009b (The 
MathWorks, Natick, MA). PCA extracted linear combinations of variables, each of which 
is associated with the largest possible variance after removing the variance of prior 
principal components in an iterative fashion. A specific category number was assigned to 
the spectra from each donor. The same category number was assigned to replicates from 
the same donor. Discriminant analysis (DA) was performed to look for the peaks with the 
highest differences between all the OA and healthy categories. PCA and DA described 
the specific spectra of different areas and distinguished between different conditions 
(healthy and OA). The scores that described the different Discriminant functions (DF) 
were adjusted to Gaussian curves following a normal distribution. The score distribution 
described the sample identity. After data analyses, m/z of interest were selected. The 
assignments of m/z identities were performed according to the bibliography and 
Lipimaps.org database (http://www.lipidmaps.org/). 
 
Lipid staining 
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For lipid staining, samples were dipped in isopropyl alcohol 60% in a closed recipient. 
Samples were then stained with an oil red solution for 20 min (oil red 0.3 gr/L in 
isopropyl alcohol). After washing in water, they were stained with hematoxylin and 
mounted. 
 
Hematoxylin staining 
 
The slides were immersed in hematoxylin (Sigma-Aldrich) for 1 min and then dipped in 
running warm tap water for 15 min for nuclei and cytoplasm staining. A wash in 
destillated water for 2 min followed by a wash in EtOH 95% (2 min) were performed 
before eosin staining (30 sec). Tissues were rinsed in deionized water (2 min), in EtOH 
95% (2x 2 min) and in EtOH 100% (2 min). Digital images were acquired with the Mirax 
system (Carl Zeiss, Siledrecht, The Netherlands) after the dehydrating steps.  
 
RESULTS AND DISCUSSION 
 
TOF-SIMS analysis of human and OA cartilage revealed an OA mass profile  
 
In the present work, we have acquired the mass spectra from 0 to 2000 Da of three 
healthy and three OA human cartilage donors in duplicate. After PCA and DA two 
different groups corresponding to healthy and OA samples were clearly distinguished in 
the positive ion mode. The highest variance, represented in the first Discriminant function 
(DF1), separated healthy and OA samples. Plotting the scores of DF1 versus the 
frequency of occurrence of these scores, two different distributions (healthy and OA) 
with a Gaussian shape were observed (figure 1A). DA revealed OA specific peaks 
according to the positive loadings of DF1. The masses that were specific to the OA 
samples were m/z 339.24, m/z 351.00, m/z 368.99, m/z 370.95, m/z 381.02 and m/z 383.26 
(figure 1B). According to the tentative assignments using the Lipidmaps database and a 
lipid MS literature search, these peaks are tentatively attributed to different fragments of 
vitamin D-3 (m/z 383.3), prostaglandins and glycerolipids (m/z 351.00, m/z 368.99, m/z 
370.95, m/z 381.02). In addition to this, the peak m/z 339.1 has been found in 
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macrophages stimulated with interferon gamma (IFN-γ) and lipopolysaccharide (LPS) 
and other authors have described it as a a monoacylglycerol MAG (C18:1) (26, 27). 
Interestingly, IFN is an inflammatory mediator related to many rheumatic diseases and 
that regulates the production of prostaglandins in cartilage and synovial tissue. Further 
analyses including MSMS-based determination of the assigned peaks are required to 
confirm this hypothesis but are beyond the current capabilities of the ToF-SIMS 
instruments currently available to us. 
Data normalization and the projection of DF1 scores were performed to study the 
distribution of OA and healthy specific masses in the two types of samples. The 
reconstruction of these images, represented a higher average intensity of the negative 
scores (DF1-) in the healthy samples (figure 2A) and a higher average intensity of the 
positive scores (DF1+) in the OA samples (figure 2B). In addition, the projection of the 
positive scores (OA specific), revealed a distribution in the superficial area of the healthy 
tissue (next to the synovial membrane tissue). In the case of OA cartilage the DF1 
positive projections, showed intense droplets, with a higher intensity in the superficial 
area compared to the deep area (next to the subchondral bone). Thus, by positive TOF-
SIMS and DA we could distinguish between healthy and OA cartilages according to a 
group of masses which were specific to each group. In addition, we were able to localize 
these aberrant molecular signatures to specific areas of the cartilage. More analyses will 
be performed in the future to study the possibility of discriminate between different OA 
grades according to the molecular signatures found. The distribution of OA peaks seemed 
to be localized in the superficial area of the cartilage. This area is in contact with synovial 
fluid, an important source of inflammatory factors extensively described in the literature 
(2, 28).  
 
PCA revealed the presence of droplets rich in lipids in OA cartilage 
 
PCA was used to analyze the intra-tissue differences in the spectral composition in 
healthy and OA cartilages independently. In the healthy samples, the first function 
separated the extracellular matrix (ECM) (represented by the positive part +1) from the 
cell membranes (represented by the negative part -1) (figure 3A). The spectra that 
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described the first PCA function, showed that cell membranes are rich in cholesterol and 
related species (figure 3B). Examples are the dominant cholesterol water-loss fragment 
[M-OH]
+
 at m/z 369, the pseudo-molecular ion [M-H]
+
 at m/z 385 and m/z 970, 
corresponding to the [2M+Au]
+
 ion. Peaks related to the Diacylglycerols (DAG) can be 
also detected in the same principal component, as exemplified by peaks at m/z 577 
(C34:1) and 603 (C36:2) respectively. The second PCA function separated the spectra of 
the lacunae (space where one or more cells are embedded) (+2) from the intracellular 
material (-2). In the OA tissue the differences between the cell membranes and the ECM 
spectra were not represented in the first function. In OA cartilage, the cholesterol species 
like the dominant cholesterol fragments [M-OH]
+
 at m/z 369 or m/z 385, m/z 970 and 
DAG (C24:1), were accumulated in droplets in the superficial area (+), and clearly 
separated from the deep ECM (figure 3A, 3C). The second function separated the ECM 
from the superficial and the deep area of the cartilage. The third function separated the 
lipid droplets in the superficial area, from the pericellular space. Thus, TOF-SIMS and 
PCA statistical analyses, revealed the intra-sample heterogeneity in healthy and OA 
human cartilage. In addition, TOF-SIMS revealed an accumulation of lipids exclusively 
in the superficial area of OA cartilages demonstrating the importance of the lipid 
metabolism alteration in the OA pathology. 
Due to the fact that the OA specific droplets were rich in lipids and negative ion mode is 
extremely suited to study fatty acids and other lipids, human healthy and OA cartilages 
were also analyzed in the negative mode. After DA the spectra of healthy and OA tissues 
were separated in two groups.  In addition, DF1 scores had a different distribution in 
healthy and OA samples, both following a Gaussian curve (figure 4A). This means that 
we are able to classify different types of cartilage samples. The first DA function 
revealed specific masses from OA cartilages (positive loadings) and healthy cartilage 
(negative loadings). Some examples of OA specific peaks were m/z 281.2 related to 
C18:1 (oleic acid) (DF loading=0.87) and other masses like m/z 255.2 from C16:0, 
(palmitic acid; DF loading=0.83), m/z 253.2 from C16:1 (palmitoleic acid; DF 
loading=0.81), m/z 283.1 from C18:0 (stearic acid; DF loading=0.73) and m/z 279.2 from 
C18:2 (linoleic acid; DF loading=0.76). The high positive loadings for these masses 
represented their specificity to OA samples. Other peaks like Vitamin E/alpha, m/z 429.2, 
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were also increased in lipid rich areas of the OA samples (29). On the other hand, the 
mass m/z 26.3 (CN
-
) was specific from healthy samples (30). CN
- 
is a marker of protein 
content and it has been associated to protein rich tissues areas (31). Cell death and tissue 
destruction are typical phenomena of the OA disease. In addition, matrix degradation 
products generated by excessive proteolysis in arthritic pathologies have been found to 
mediate cartilage destruction, explaining the lower protein abundance in OA tissues. The 
decreased m/z 26 intensity in OA cartilage is supported by this theory. 
The study of the raw data acquired after TOF-SIMS tissue experiments already showed 
the differences in ion intensity in some of the masses of interest, confirming the results 
obtained after data reduction and interpretation. Figure 5A exemplifies the average raw 
spectra over the entire section of a healthy and an OA sample (m/z range of 200-400) 
measured in the negative mode. A higher intensity of m/z 255.2 and 281.2 was observed 
in OA tissues. Figure 5B represents a spectrum in the mass range of 0-200 m/z in the 
negative mode revealing and displaying a higher intensity of m/z 26 in the healthy 
samples.  
As explained above PCA and DA were employed to study the distribution and the 
intensities of several groups of masses. We have also studied by univariate analyses the 
distribution of OA specific masses (m/z 253.2, m/z 255.2, m/ 279.2, m/z 281.2, m/z 283.1 
and m/z 429.2) (figure 6). With the exception of palmitoleic acid (m/z 253.2) that 
exhibited a more general distribution, all the masses were located in the cholesterol rich 
areas. According to Leistad et al., a liberation of oleic acid can be produced when 
chondrocytes are stimulated with tumor necrosis factor (TNF), one of the main mediators 
of inflammatory processes (32). An important number of masses in the mass range of 
phospholipids (600-900) have been found in the OA samples according to the DA. The 
FA detected and here described as masses specific to the OA condition, could be part of 
these lipids. Future parallel studies using MALDI-imaging for instance, could 
discriminate these intact lipids as other authors have shown (33-35).   
Alteration in cholesterol and lipid content have been associated in many diseases related 
to age like obesity or diabetes (30). In neurodegenerative diseases lipid anomalies 
potentially linked to Alzheimer Disease (AD) have been also reported by mass 
spectrometry (36) and, in cardiovascular pathogenesis, the accumulation of cholesterol is 
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one of the primary risk factors (37, 38). In the case of the cartilage, only few authors have 
studied the lipid metabolism of chondrocyte cells. A relation between cartilage lesion and 
alterations in the lipid metabolism has been found by techniques such as electron 
microscopy (39, 40). Finally, FA, DAG and other lipids have been detected in high 
concentrations in plasma of OA patients by LC-chromatography (41) supporting our 
results.  
 
Validation of lipid localization 
 
As we explained above, the specific deposition of lipid precipitates in the OA samples 
was an interesting feature that suggested the metabolic alteration of OA cartilage cells. 
The local environment can have an effect in the ionization of specific molecules. Since 
the ECM can vary in composition between different areas of the cartilage and this could 
affect the ionization, it is important to validate the results we found with other techniques 
to make solid conclusions. We validated the content of these lipid droplets by oil red 
staining.  Figure 7 shows the lipid distribution in healthy and OA cartilage. In OA 
samples big lipid droplets (red) were observed in the superficial area of the cartilage, 
confirming the TOF-SIMS results. The oil red stain merely confirms the compound class 
present. Unlike TOF-SIMS it provides no hints towards the actual chemical composition 
and acyl chain length distribution. The fact that all these lipid related species were 
localized in droplets in the superficial area, revealed the important role of the adjacent 
tissues (synovial membrane) and fluids (synovial fluid) in the process of inflammation 
and destruction of the cartilage. The pathways involved in the cross-talk between 
cartilage and other tissues are not completely understood. Here we have revealed a clear 
pathological role of lipid related molecular pathways in the OA pathology. We therefore 
conclude that an alteration in the lipid metabolism could be a risk factor and/or a 
consequence of the OA disease that should be studied in detail. 
 
Different localization of elemental ions 
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Defects in ion pumps, homeostasis ion regulation and cell death are other characteristics 
of OA chondrocytes (42). Thus, alterations in the electrolyte balance can cause changes 
in the cartilage. The visualization of masses corresponding to elementary molecules 
reported interesting information. The study of the localization and the intensity of sodium 
ions were similar in both types of samples (supplementary figure 2). However the 
calcium signal (m/z 40) was distributed in deposits in the ECM. Other species measured 
in the negative mode, like the chlorine (m/z 35) had a similar distribution although a 
slightly lower intensity in OA than in healthy samples. We confirmed also a lower 
intensity of CN
-
 in OA samples, especially in the areas with high content of lipids. We 
have also observed deposits of phosphates PO
2-
 (m/z 63.1) and PO
3- 
(m/z 79.2) only in 
OA cartilages. The calcification of the cartilage is another consequence of the OA 
pathology. The detection of crystals rich in calcium phosphate in synovial liquid from 
patients with OA and an increase in calcium and phosphorus levels in the OA cartilage, 
have been described in the literature (43, 44). All these facts contribute to the production 
of prostaglandins, other inflammatory factors and to change the biomechanical properties 
of the cartilage. 
 
 
 
 
CONCLUSIONS 
 
In this study we investigated the possibility of using TOF–SIMS as a new method for the 
detection of changes in lipid and elemental composition in healthy and OA human 
cartilage. We were able to describe an OA specific peak profile. Accumulation of 
cholesterol and FA was detected in the superficial area of the OA cartilage. A disease 
specific accumulation of calcium and phosphates was observed only in OA cartilage. 
These results demonstrate that TOF-SIMS is a useful tool in the study of lipid and 
elemental composition changes associated with rheumatic pathologies with excellent 
diagnostic potential. 
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FIGURES 
Figure 1 
 
Figure 1. Discriminant analyses revealed a different mass spectrum in healthy and 
OA human cartilage after positive TOF-SIMS. A) Histogram distribution of DF1 
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scores where negative scores were specific to healthy samples and positive scores to OA 
samples. B) Spectra plot of the DF1. The list of OA specific peaks is shown. 
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Figure 2 
 
 
 
 
 
 
Figure 2. First discriminant function (DF1) score plot projections. The distribution of 
healthy (DF1-) and OA (DF1+) scores was studied. Superficial and deep areas are 
labeled. A) DF1 negative scores projection. The intensity of DF1 negative scores was 
higher in healthy than in OA cartilages. X and y axes represent the pixel number. B) The 
intensity of DF1 positive scores was higher in OA compared to healthy cartilages. The 
distribution was specific to the superficial area (next to the synovial membrane), in the 
case of OA cartilage in small droplets. X and y axes represent the pixel number. 
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Figure 3 
 
 
 
Figure 3. Principal component analyses of healthy and OA human cartilage revealed 
intra-sample heterogeneity. Superficial and deep areas are labeled. A) First three PCA 
functions in healthy and OA cartilages (positive mode). B) Spectra of the first PCA 
function in healthy cartilage that shows the lipid content of the cellular membranes (-1). 
Cholesterol (star) and DAG masses (circle) are shown. C) Spectra of the first PCA 
function in OA cartilage. Cholesterol and DAG masses are shown. Cholesterol and lipid 
droplets can be appreciated in the superficial area, exclusively in OA samples. 
A) B) 
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Figure 4 
 
 
Figure 4. Discriminant analyses revealed a different spectrum in healthy and OA 
human cartilage in the negative mode. A) Histogram distribution of DF1 scores where 
negative scores were specific to healthy samples and positive scores to OA samples. B) 
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Spectra plot of the DF1. Fatty acids (m/z 253.2, m/z 255.2, m/ 279.2, m/z 281.2, m/z 
283.1) were more abundant in OA cartilage. 
 
Figure 5 
 
 
Figure 5. Raw spectra of A) 200-400 m/z and B) 0-200 m/z acquired in the negative 
mode. The figure shows the differences in the intensity of selected masses like palmitic 
acid (m/z 255.2), oleic acid (m/z 281.2) and CN- (m/z 26). 
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Figure 6 
 
 
 
Figure 6. Intensity and distribution of OA specific masses detected in the negative 
mode. Different masses m/z 255.2, m/ 279.2, m/z 281.2, m/z 283.1 and m/z 426.2 were 
specifically localized in the superficial area of the OA cartilage (next to the synovial 
membrane). 
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Figure 7 
 
 
 
 
Figure 7. Oil red/hematoxylin staining in healthy and OA cartilages validated TOF-
SIMS experiments. Lipid droplets can be appreciated in the superficial area of the OA 
cartilage. 
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For TOC only 
 
 
 
Abstract graphic. TOF-SIMS and the study of the cartilage composition. The figure 
shows the representation of the human joint and cartilage with a schematic of a human 
joint and a hematoxylin-eosin staining of cartilage. The figure also shows an overlay of 
the third (+3/-3) and the first PCA functions (+1) in a healthy cartilage after TOF-SIMS 
measurements. Each color represents a specific spectrum, distinguishing the chondrocyte 
cells (pink color), the lacunae (blue color) and the extracellular matrix (green) among 
other areas. The spectra of first PCA function is shown, revealing the specific 
composition of cells (rich in cholesterol and other lipids). 
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